MedPath

Effect validation of Meta-cognitive training as a Transdiagnostic Approach

Not Applicable
Conditions
Mental disorders such as schizophrenia, mood disorder, anxiety disorder
Registration Number
JPRN-UMIN000032393
Lead Sponsor
niversity of Miyazaki,Fuculty of Medicine,School of Nursing
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) individuals who have scores above 5 in "hostility", or above 6 "suspicion" of PANSS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EuroQol-5 dimensions-5 levels (EQ-5D-5L) (1)Pre MCT (2)Five weeks after the beginning of MCT (3)Post MCT (4)Four weeks follow-up
Secondary Outcome Measures
NameTimeMethod
Cognitive Bias Questionnaire for psychosis(CBQp) The scores of positive symptoms in PANSS Global Assessment of Functioning(GAF) Beck Cognitive Insight Scale(BCIS) Beck Depression Inventory 2(BDI-2) Exploratory Outcomes: Self-Efficacy for Community Life Scale of Schizophrenia(SECL) Maladaptive and Adaptive Coping Styles Questionnaire(MAX) Rosenberg Self-esteem Scale(RSES) (1)Pre MCT (2)Five weeks after the beginning of MCT (3)Post MCT (4)Four weeks follow-up
© Copyright 2025. All Rights Reserved by MedPath